What MDS Misdiagnoses Trends Tells Us About Blood Cancer Diagnostics
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Unknown Origin & Other Cancer Types |
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Coagulation Testing |
HemoSonics announced its Quantra Hemostasis System received an Innovative Technology contract award from Vizient.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Company News, Hematology Instrumentation |
Roche will continue to offer Sysmex’ hematology products, complementing their total lab solutions portfolio, the companies say.
Read MorePosted by Andy Lundin | Jul 25, 2023 | Point-of-Care |
The VitalOne allows doctors to test, diagnose, and treat patients in a single visit. Patients receive results within 20 minutes.
Read MorePosted by Chris Wolski | Jul 12, 2023 | Diagnostic Technologies |
Daxor Corporation has announced expansion of blood volume analysis (BVA) into five of six hospitals in the Southeast.
Read More